Search results
Found 5063 matches for
A collaboration between the Russell group (Chemistry and Pharmacology) and the Davies group (Physiology, Anatomy and Genetics) has identified, via a chemical proteomics and phenotypic profiling strategy, the arylhydrocarbon receptor (AhR) as the molecular target of ezutromid, the utrophin modulator that recently completed a Phase 2 clinical trial in Duchenne muscular dystrophy patients.
Liang Wu
Liang Wu - Deputy lead - Molecular Perturbations Challenge, Rosalind Franklin Institute
Harriet Haysom
Harriet Haysom - Postdoctoral Research Assistant in Chemical Biology and Antimicrobial Resistance
Fahimeh Khorsand
Fahimeh Khorsand - Postdoctoral Research Assistant in Chemical/Cell Biology and Antimicrobial Resistance
